Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Nautilus Biotechnology, Inc. (NAUT) had Current Assets of $87.63M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.19M |
|
$-14.47M |
|
$0.01M |
|
$0.17M |
|
$15.95M |
|
$-15.76M |
|
$1.29M |
|
$-14.47M |
|
$-14.47M |
|
$-14.47M |
|
$-14.47M |
|
$-14.47M |
|
$-14.47M |
|
$-15.76M |
|
$-14.47M |
|
127.14M |
|
127.14M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
|
Current Assets |
$87.63M |
$4.00M |
|
$75.95M |
|
$163.58M |
|
$8.64M |
|
-- |
|
$23.82M |
|
$32.46M |
|
$131.11M |
|
$131.11M |
|
$131.11M |
|
127.22M |
|
| Cash Flow Statement Financials | |
$-26.83M |
|
$26.25M |
|
$1.35M |
|
$13.39M |
|
$14.17M |
|
$0.78M |
|
$2.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
92.11% |
|
-8296.32% |
|
-8296.32% |
|
-- |
|
-7615.26% |
|
-7615.26% |
|
$-27.79M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-11.04% |
|
-11.04% |
|
-8.85% |
|
-11.04% |
|
$1.03 |
|
$-0.22 |
|
$-0.21 |
|